Back to Search
JENNIFER GRAYBILL, DO
DO
Internal Medicine Physician
NPI: 1497016406IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine Physician
Family Medicine
Code: 207Q00000X
OS13602(FL)
Rheumatology Physician
Internal Medicine — Rheumatology
Code: 207RR0500X
266937(NY)
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
OS13602(FL)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE
Class of 2007
Research & Publications (20)
Posaconazole therapy of disseminated phaeohyphomycosis in a murine model.
PMID 15155236·Antimicrob Agents Chemother·2004
7-preclinical
Antifungal therapy of murine Aspergillus terreus infection.
PMID 15388425·Antimicrob Agents Chemother·2004
7-preclinical
Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafungin.
PMID 12972452·J Antimicrob Chemother·2003
7-preclinical
Improving the mouse model for studying the efficacy of voriconazole.
PMID 12746374·J Antimicrob Chemother·2003
7-preclinical
The echinocandins, first novel class of antifungals in two decades: will they live up to their promise?
PMID 11770362·Int J Clin Pract·2001
8-other
Consensus statement on the management of invasive candidiasis in Intensive Care Units in the Asia-Pacific Region.
PMID 19409759·Int J Antimicrob Agents·2009
8-other
Inhaled voriconazole for prevention of invasive pulmonary aspergillosis.
PMID 19289523·Antimicrob Agents Chemother·2009
7-preclinical
The north and south of candidemia: Issues for Latin America.
PMID 18810276·Drugs Today (Barc)·2008
6-review
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.
PMID 18637757·Clin Infect Dis·2008
6-review
Evaluation of aminocandin and caspofungin against Candida glabrata including isolates with reduced caspofungin susceptibility.
PMID 18658194·J Antimicrob Chemother·2008
4-observational
Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture.
PMID 18474582·Antimicrob Agents Chemother·2008
7-preclinical
Therapeutic and prophylactic efficacy of aminocandin (IP960) against disseminated candidiasis in mice.
PMID 18397335·Clin Microbiol Infect·2008
7-preclinical
Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant.
PMID 18813103·Transplantation·2008
8-other
Assessment of serum (1->3)-beta-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis.
PMID 18160526·Antimicrob Agents Chemother·2008
7-preclinical
Posaconazole as salvage treatment of invasive fungal infections in patients with underlying renal impairment.
PMID 18835806·J Antimicrob Chemother·2008
3-trial
Voriconazole in the treatment of fungal eye infections: a review of current literature.
PMID 18577634·Br J Ophthalmol·2008
6-review
Antimicrobial resistance prevention initiative--an update: proceedings of an expert panel on resistance.
PMID 17980231·Am J Infect Control·2007
6-review
Therapeutic efficacy of caspofungin alone and in combination with amphotericin B deoxycholate for coccidioidomycosis in a mouse model.
PMID 17934204·J Antimicrob Chemother·2007
7-preclinical
Histological, CT, and intraoperative ultrasound appearance of hepatic tumors previously treated by laparoscopic radiofrequency ablation.
PMID 17653812·J Gastrointest Surg·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1111 7TH AVE N STE 107
SAINT PETERSBURG, FL 33705 - Phone
- (727) 894-1661
Quick Facts
- NPI
- 1497016406
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 19
- Publications
- 20
Are you this provider?
Claim Your Profile